Advancing Continous Concentration with Patented Cadence Single-Pass TFF
Single-pass tangential flow filtration (SPTFF) technology from Pall Life Science is a versatile concentration approach for biotech, vaccine and plasma industry applications. Patented Cadence™ SPTFF technology offers a total solution for inline volume reduction and/or concentration, in-process dilution/de-salting, high concentration formulations, and processing of fragile molecules, crucially enabling integrated, streamlined and continuous bioprocessing initiatives.
Moderator
Kevin Marino
Global Product Manager, Continuous Filtration
Pall Biotech
Speakers
Jon Petrone
Senior Director, SLS Bioprocess Integration Team
Pall Biotech
Advancing Continous Concentration with Patented Cadence Single-Pass TFF
See how you can save up to 30% on the cost of goods per batch
Biotech | Pall Corporation webinar series
Integrity Assurance for Single-Use Systems An End-User’s Perspective
What should you consider when building an integrity control strategy for your single-use systems (SUS)? How do you overcome application challenges?
Join leading industry experts Charlotte Masy of GSK and Patrick Evrard from Pall Corporation to gain insights and answers in this webinar from BioPharma Asia on integrity Assurance for Single-Use Systems, an End-User’s Perspective. They will present several case studies to show how integrity concerns can be practically addressed for cGMP manufacturing applications and the results observed a few years on.
Attendees will learn about:
- The latest regulatory requirements for integrity assurance of SUS
- The different technologies available to control integrity of SUS
- Key parameters that affect integrity measurements
Register now for this webinar from industry experts on October 6.